Mylotarg 5 mg/5mL (Gemtuzumab Ozogamicin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 5 mg/5mL

Mylotarg 5 mg/5mL is a lyophilized powder for solution, used for intravenous administration. This medication contains gemtuzumab ozogamicin, a targeted therapy for certain types of cancer. It is designed to deliver a cytotoxic agent directly to cancer cells, potentially reducing side effects on healthy cells.

Strength

5 mg/5mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0008-4510-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mylotarg is primarily used in the treatment of acute myeloid leukemia (AML). It works by targeting a specific protein found on the surface of leukemia cells, allowing the delivery of a cytotoxic agent directly to these cells. This targeted approach aims to minimize damage to healthy cells, which is a common concern with traditional chemotherapy. Patients and healthcare providers often explore what Mylotarg is used for in the context of managing AML and other related conditions.

Side Effects

Common effects of Mylotarg may include infusion-related reactions, such as fever, chills, and nausea. Some patients may also experience fatigue, vomiting, and an increased risk of infection. These effects can vary widely among individuals, and it is important to discuss any concerns with a healthcare provider. The specific effects experienced can depend on the individual's overall health and the dosage administered.

Precautions & Warnings

Mylotarg should be handled with care, as it is a potent medication. It is important to follow proper storage and administration guidelines to ensure safety. Patients should be monitored for signs of infusion-related reactions and other adverse effects. Additionally, healthcare providers should be aware of the potential for liver toxicity and other serious side effects, and appropriate precautions should be taken.

Avoid Interactions

Mylotarg may interact with other medications, particularly those that affect the liver or immune system. It is important to inform healthcare providers about all medications being taken, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with Mylotarg, so patients should follow their healthcare provider's advice regarding diet and lifestyle during treatment.

Frequently Asked Questions

Mylotarg is used in the treatment of acute myeloid leukemia (AML). It targets a specific protein on leukemia cells to deliver a cytotoxic agent directly to these cells.

Mylotarg is administered intravenously as a solution prepared from a lyophilized powder. It should be given by a healthcare professional in a clinical setting.

Common side effects may include infusion-related reactions like fever and chills, as well as fatigue, nausea, and an increased risk of infection.

Mylotarg may interact with other medications, especially those affecting the liver or immune system. Always consult a healthcare provider before combining treatments.

Patients should be monitored for infusion-related reactions and other adverse effects. Proper storage and administration guidelines should be followed to ensure safety.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.